story of the week
Proton Pump Inhibitors Increase Risk of Charles Bonnet Syndrome in AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Investigative Ophthalmology & Visual Science
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors
Invest. Ophthalmol. Vis. Sci 2017 Aug 01;58(10)4138-4142, JE Leandro, J Beato, AC Pedrosa, J Pinheiro-Costa, M Falcão, F Falcão-Reis, ÂM CarneiroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.